| Sigma Labs, Inc. | |||||||
| Condensed Statements of Operations | |||||||
| (Unaudited) | |||||||
| Twelve Months | Twelve Months | ||||||
| December 31, 2017 | December 31, 2016 | ||||||
| REVENUES | $ | 641,049 | $ | 942,222 | |||
| COST OF REVENUES | 272,372 | 228,902 | |||||
| GROSS PROFIT | 368,677 | 713,320 | |||||
| EXPENSES | |||||||
| Salaries & Benefits | 1,509,672 | 1,230,267 | |||||
| Stock-Based Compensation | 719,796 | 341,558 | |||||
| Operating & R&D Costs | 302,043 | 120,638 | |||||
| Investor & Public Relations | 666,003 | 621,407 | |||||
| Legal & Professional Services Fees | 563,300 | 313,432 | |||||
| Office Expense | 324,920 | 272,895 | |||||
| Depreciation & Amortization | 196,943 | 178,841 | |||||
| Other Operating Expenses | 137,989 | 132,220 | |||||
| Total Expenses | 4,420,667 | 3,211,258 | |||||
| OPERATING INCOME | (4,051,990 | ) | (2,497,938 | ) | - | ||
| OTHER INCOME (EXPENSE) | |||||||
| Interest Income | 40,107 | 355 | |||||
| State Incentives | 154,568 | 51,703 | |||||
| Decrease in fair value of derivative liabilities | (186,908 | ) | 354,644 | ||||
| Interest Expense | (161,852 | ) | (40,228 | ) | |||
| Loss on Disposal of Assets | (13,161 | ) | - | ||||
| Debt Discount Amortization | (358,280 | ) | (89,570 | ) | |||
| Total Other Income | (525,526 | ) | 276,904 | ||||
| LOSS BEFORE PROVISION FOR INCOME TAXES | (4,577,516 | ) | (2,221,034 | ) | |||
| Provision for income Taxes | - | - | |||||
| Net Loss | $ | (4,577,516 | ) | $ | (2,221,034 | ) | |
| Net Loss per Common Share - Basic and Diluted | $ | (1.04 | ) | $ | (0.71 | ) | |
| Weighted Average Number of Shares | |||||||
| Outstanding - Basic and Diluted | 4,403,479 | 3,125,022 | |||||
Sigma Labs Announces Full Year 2017 Financial Results
 |  | More MCAD News
|
|
RELATED NEWS
